Brain zap study reveals secrets of speech learning
NCT ID NCT07455760
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how two brain areas—the subthalamic nucleus and the ventral intermediate nucleus of the thalamus—help us learn and produce speech. Researchers will temporarily turn deep brain stimulation (DBS) on or off in 80 people with Parkinson's disease or essential tremor while they practice saying new sound sequences. The goal is to understand how DBS affects speech learning, which may lead to better DBS settings that improve both movement and speech.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- deep brain stimulation (DBS) targeting the subthalamic nucleus or ventral intermediate nucleus of the thalamus
- What this could lead to
- If successful, this research could guide doctors in fine-tuning DBS settings to better preserve or improve speech in people with Parkinson's disease or essential tremor.
- What could go wrong
- This is an early-stage observational study with only 80 participants, so results may not apply to everyone. The temporary turning off of DBS may cause discomfort or temporary worsening of symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Aug 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Native speakers of American English * Adults at least 18 years of age * A clinically established diagnosis of Parkinson's disease or essential tremor * Able to provide informed consent in the judgment of the investigator * Treated with deep brain stimulation of the subthalamic nucleus (Parkinson's disease) or ventral intermediate nucleus of the thalamus (essential tremor) * Stable Parkinson's disease or essential tremor medication regimen for at least one month * Stable DBS program settings for at least one month * Nominal DBS system function, including normal impedances at therapeutic DBS contacts, and adequate battery life or adequate IPG charging status for therapy * For DBS sensing, implanted with Medtronic Percept PC or Percept RC implantable pulse generator * Corrected vision adequate to easily read text presented during speech motor task Exclusion Criteria: * Cognitive impairment (Montreal Cognitive Assessment (MoCA; Nesreddine et al., 2005) score \< 25) or active psychotic or behavioral symptoms that would, in the judgment of the investigator, preclude proper participation in the study * Hearing impairment that interferes with accurate perception of the speech motor learning stimulus (25dB hearing level threshold at 500, 1k, 2k, and 4kHz frequencies) * Language impairment (aphasia) or speech articulation impairment (dysarthria) that precludes performance of the speech motor learning task * Neurological disorder that interferes with speech motor learning * Inability to tolerate symptoms when DBS is off * Orthodontia or atypical oral structure (e.g., cleft palate) that interferes with speech * Pregnancy * For participants in the sub-syllabic sequence learning study (Study C.2.1), experience with the following languages: Hebrew, Polish, Lithuanian, Romanian, Georgian, Tepehua, Hungarian, and Pima
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Essential tremor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Boston University
RECRUITINGBoston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Hair-Thin electrodes tested to Fine-Tune brain stimulation
- Brain training through implanted electrodes aims to quiet Parkinson's tremors
- Can brain stimulation be tuned to improve sleep in Parkinson's?
- Can new brain stimulation patterns quiet stubborn tremors?
- AI hunts for early clues to Parkinson's and Alzheimer's progression